高级检索
当前位置: 首页 > 详情页

The Protective Effect of (-)-Tetrahydroalstonine against OGD/R-Induced Neuronal Injury via Autophagy Regulation

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Cardiovascular Surgery, The First Affiliated Hospital, Jinan University, Guangzhou 510632, China [2]JNU-HKUST Joint Laboratory for Neuroscience and Innovative Drug Research, College of Pharmacy, Jinan University, Guangzhou 510632, China [3]Guangdong Provincial Engineering Research Center for Modernization of TCM, College of Pharmacy, Jinan University, Guangzhou 510632, China [4]Centro Hospitalar Conde de São Januário, Macau, China [5]NMPA Key Laboratory for Quality Evaluation of TCM, Jinan University, Guangzhou 510632, China
出处:

关键词: (-)-Tetrahydroalstonine cerebral ischemia OGD/R autophagy Akt/mTOR

摘要:
Here, (-)-Tetrahydroalstonine (THA) was isolated from Alstonia scholaris and investigated for its neuroprotective effect towards oxygen-glucose deprivation/re-oxygenation (OGD/R)-induced neuronal damage. In this study, primary cortical neurons were pre-treated with THA and then subjected to OGD/R induction. The cell viability was tested by the MTT assay, and the states of the autophagy-lysosomal pathway and Akt/mTOR pathway were monitored by Western blot analysis. The findings suggested that THA administration increased the cell viability of OGD/R-induced cortical neurons. Autophagic activity and lysosomal dysfunction were found at the early stage of OGD/R, which were significantly ameliorated by THA treatment. Meanwhile, the protective effect of THA was significantly reversed by the lysosome inhibitor. Additionally, THA significantly activated the Akt/mTOR pathway, which was suppressed after OGD/R induction. In summary, THA exhibited promising protective effects against OGD/R-induced neuronal injury by autophagy regulation through the Akt/mTOR pathway.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 2 区 化学
小类 | 3 区 化学:综合 3 区 生化与分子生物学
最新[2025]版:
大类 | 3 区 化学
小类 | 3 区 生化与分子生物学 3 区 化学:综合
第一作者:
第一作者机构: [1]Department of Cardiovascular Surgery, The First Affiliated Hospital, Jinan University, Guangzhou 510632, China [2]JNU-HKUST Joint Laboratory for Neuroscience and Innovative Drug Research, College of Pharmacy, Jinan University, Guangzhou 510632, China
共同第一作者:
通讯作者:
通讯机构: [3]Guangdong Provincial Engineering Research Center for Modernization of TCM, College of Pharmacy, Jinan University, Guangzhou 510632, China [5]NMPA Key Laboratory for Quality Evaluation of TCM, Jinan University, Guangzhou 510632, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号